GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
25/05/22	GSK	15:41:00	25 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
01/03/22	GSK	14:30:15	1 Mar 2022	Total Voting Rights	GSK	Total Voting Rights	GlaxoSmithKline PLC	RNS
01/03/22	GSK	13:18:53	1 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
01/03/22	GSK	09:55:43	1 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
01/03/22	GSK	07:00:05	1 Mar 2022	Daprodustat application accepted for review by EMA	GSK	Daprodustat application accepted for review by EMA	GlaxoSmithKline PLC	RNS
28/02/22	GSK	11:00:02	28 Feb 2022	GSK introduces Haleon to investors	GSK	GSK introduces Haleon to investors	GlaxoSmithKline PLC	RNS
28/02/22	GSK	07:00:07	28 Feb 2022	GSK RSV maternal vaccine candidate further update	GSK	GSK RSV maternal vaccine candidate further update	GlaxoSmithKline PLC	RNS
24/02/22	GSK	16:22:10	24 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
24/02/22	GSK	15:12:57	24 Feb 2022	Canada Approval For Medicago GSK Covid-19 Vaccine	GSK	Canada Approval For Medicago GSK Covid-19 Vaccine	GlaxoSmithKline PLC	RNS
23/02/22	GSK	14:50:13	23 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
22/02/22	GSK	14:00:00	22 Feb 2022	GSK Consumer Healthcare to be called Haleon	GSK	GSK Consumer Healthcare to be called Haleon	GlaxoSmithKline PLC	RNS
22/02/22	GSK	09:22:02	22 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
18/02/22	GSK	16:30:47	18 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
18/02/22	GSK	07:00:09	18 Feb 2022	GSK gives update on RSV maternal vaccine candidate	GSK	GSK gives update on RSV maternal vaccine candidate	GlaxoSmithKline PLC	RNS
17/02/22	GSK	16:00:07	17 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/02/22	GSK	15:40:07	17 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/02/22	GSK	15:20:07	17 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/02/22	GSK	14:50:06	17 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/02/22	GSK	14:19:13	17 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/02/22	GSK	18:04:29	16 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
14/02/22	GSK	17:50:29	14 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
14/02/22	GSK	13:26:53	14 Feb 2022	Transfer of Treasury Shares	GSK	Transfer of Treasury Shares	GlaxoSmithKline PLC	RNS
11/02/22	GSK	14:06:36	11 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/02/22	GSK	09:33:46	11 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
10/02/22	GSK	09:00:02	10 Feb 2022	Benlysta approved in China for Lupus Nephritis	GSK	Benlysta approved in China for Lupus Nephritis	GlaxoSmithKline PLC	RNS
09/02/22	GSK	11:07:38	9 Feb 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
09/02/22	GSK	07:00:07	9 Feb 2022	Final Results	GSK	Final Results	GlaxoSmithKline PLC	RNS
07/02/22	GSK	10:30:58	7 Feb 2022	Publication of full year 2021 results: Replacement	GSK	Publication of full year 2021 results: Replacement	GlaxoSmithKline PLC	RNS
07/02/22	GSK	10:00:01	7 Feb 2022	Publication of full year 2021 results	GSK	Publication of full year 2021 results	GlaxoSmithKline PLC	RNS
02/02/22	GSK	07:00:05	2 Feb 2022	GSK announces settlement between ViiV and Gilead	GSK	GSK announces settlement between ViiV and Gilead	GlaxoSmithKline PLC	RNS
01/02/22	GSK	13:44:38	1 Feb 2022	FDA approves ViiV Healthcare’s sNDA for Cabenuva	GSK	FDA approves ViiV Healthcare’s sNDA for Cabenuva	GlaxoSmithKline PLC	RNS
01/02/22	GSK	11:44:03	1 Feb 2022	Total Voting Rights	GSK	Total Voting Rights	GlaxoSmithKline PLC	RNS
26/01/22	GSK	16:48:03	26 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
20/01/22	GSK	15:59:20	20 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
19/01/22	GSK	16:33:13	19 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
19/01/22	GSK	15:14:38	19 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
19/01/22	GSK	15:10:04	19 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
19/01/22	GSK	07:00:57	19 Jan 2022	Tony Wood appointed CSO Designate, GSK	GSK	Tony Wood appointed CSO Designate, GSK	GlaxoSmithKline PLC	RNS
17/01/22	GSK	17:04:18	17 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/01/22	GSK	15:07:50	17 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/01/22	GSK	07:00:05	17 Jan 2022	Update - GSK Consumer Healthcare	GSK	Update - GSK Consumer Healthcare	GlaxoSmithKline PLC	RNS
14/01/22	GSK	15:22:51	14 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/01/22	GSK	16:12:43	13 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/01/22	GSK	16:28:37	11 Jan 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/01/22	GSK	12:08:21	11 Jan 2022	US Govt buys additional 600,000 sotrovimab doses	GSK	US Govt buys additional 600,000 sotrovimab doses	GlaxoSmithKline PLC	RNS
04/01/22	GSK	12:28:56	4 Jan 2022	Total Voting Rights	GSK	Total Voting Rights	GlaxoSmithKline PLC	RNS
23/12/21	GSK	13:11:05	23 Dec 2021	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
22/12/21	GSK	14:57:00	22 Dec 2021	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
21/12/21	GSK	07:00:02	21 Dec 2021	ViiV Healthcare announces FDA approval of Apretude	GSK	ViiV Healthcare announces FDA approval of Apretude	GlaxoSmithKline PLC	RNS

Showing 951–1000 of 2,803 announcements